Advertisement

Here is the rundown on market activity for Stryker Corporation (NYSE:SYK). Group President, Orthopaedics David Floyd sold 19,305 shares at an average price of $144.56 on Wed the 12th. Floyd now owns $1,238,590 of stock per an SEC filing yesterday. David Floyd, Group President, Orthopaedics sold $1,068,031 worth of shares at an average price of $144.70 on Mon the 5th. That brings the Group President, Orthopaedicss holdings to $4,033,223 as reported to the SEC.

Timothy J. Scannell, Group President sold $1,810,327 worth of shares at an average price of $135.89 on May 2nd. That brings Scannells holdings to $15,576,119 as recorded in a recent Form 4 SEC filing.

Stryker Corporation (Stryker), launched on February 20, 1946, is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Businesss segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products. The Businesss MedSurg segment consists of instruments, endoscopy, medical and sustainability products. The Neurotechnology and Spine segment includes neurovascular products, spinal implant systems and other related products..

These funds have also shifted positions in (SYK). Eqis Capital Management, Inc. added to its stake by buying 1,575 shares an increase of 10.3% as of 06/30/2017. Eqis Capital Management, Inc. owns 16,877 shares valued at $2,342,000. The value of the position overall is up by 16.3%. As of the end of the quarter Old National Bancorp /in/ had sold a total of 241 shares trimming its holdings by 4.9%. The value of the investment in (SYK) went from $647,000 to $649,000 increasing 0.3% quarter over quarter.

As of quarter end Lejeune Puetz Investment Counsel LLC had disposed of 240 shares trimming its position 6.1%. The value of the investment in SYK decreased from $516,000 to $511,000 a change of 1.0% quarter to quarter. As of the end of the quarter Central Trust Co had sold a total of 200 shares trimming its stake by 5.6%. The value of the investment in Stryker Corporation decreased from $467,000 to $465,000 a change of $2,000 since the last quarter.

Cantor Fitzgerald added SYK to its research portfolio with a rating of Neutral. On May 16 analysts at Goldman Sachs started covering SYK giving it an initial rating of Neutral.

On December 15 the stock rating was upgraded to Buy from in a statement from UBS. On November 1 the company was upgraded from Underperform to Market Perform in a report from BMO Capital.

Equity analyst SunTrust Robinson Humphrey issued its first research report on the stock setting a rating of Buy. On June 9, 2016 Guggenheim Securities initiated coverage on SYK with an initial rating of Buy.

The company is so far trading up from yesterdays close of $143.2. Additionally Stryker Corporation announced a dividend that will be paid on Monday the 31st of July 2017. The dividend payment will be $0.425 per share for the quarter or $1.70 on an annualized basis. This dividend represents a yeild of $1.18 which is the dividend as a percentage of the current share price. The ex-dividend date will be Wednesday the 28th of June 2017.

Shares of the company are trading at $145.40 just above the 50 day moving average which is $140.23 and barely above the 200 day moving average of $130.49. The 50 day moving average went up by +3.68% and the 200 day average was up $14.91.

The company currently has a P/E ratio of 32.67 and market capitalization is 54.35B. In the latest earnings report the EPS was $4.45 and is projected to be $6.43 for the current year with 373,765,000 shares outstanding. Next quarters EPS is forecasted to be $1.52 with next years EPS anticipated to be $7.05.

Link:

Insider Activity Stryker Corporation (NYSE:SYK) - Highlight Press